Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.
April 27 (Reuters) - Medical equipment maker Thermo Fisher Scientific said on Monday it would sell its microbiology business to private equity firm Astorg for about $1.08 billion. • Deal consists of ...
Eighteen Americans who were aboard the cruise ship at the center of the deadly hantavirus outbreak are being monitored at ...
Passengers disembark the MV Hondius at the port of Granadilla in Tenerife, Canary Islands. (Associated Press) The cruise ship ...
PAC doubles spend in key Democratic primary races to fight Trump and RFK Jr’s ‘war on science’ - Exclusive: 3.14 Action Fund ...
Even minimal exposure to modern medicine can rapidly change the human microbiome. In a new study appearing in Cell Reports, ...
Billionaire Femi Otedola praises the Dangote Petroleum Refinery tour, sharing impactful insights and stirring online ...
Advances in artificial intelligence (AI) are transforming the way we analyze, model, and interpret both microbial systems and complex biomedical data.
Researchers have long known that bacteria could potentially be used to deliver therapeutic drugs inside the human body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results